S H Kelkar & Co.

  • Market Cap: Small Cap
  • Industry: Specialty Chemicals
  • ISIN: INE500L01026
  • NSEID: SHK
  • BSEID: 539450
INR
136.85
-1.95 (-1.4%)
BSENSE

Sep 18, 03:30 PM

BSE+NSE Vol: 9.26 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

9.26 lacs (52.51%) Volume

Shareholding (Jun 2026)

FII

5.92%

Held by 49 FIIs

DII

6.01%

Held by 7 DIIs

Promoter

54.87%

Why is S H Kelkar & Company Ltd falling/rising?

06-Sep-2026

As of 05-Sep, S H Kelkar & Company Ltd's stock price has risen by 0.7% to 151.50, reflecting short-term gains and positive moving averages. However, it has declined 43.25% over the past year, indicating long-term underperformance and fundamental weaknesses that may warrant caution among investors.

As of 05-Sep, S H Kelkar & Company Ltd's stock price is currently rising, having increased by 1.05 (0.7%) to a current price of 151.50. This rise can be attributed to a recent trend where the stock has been gaining for the last three days, resulting in a total return of 1.72% during this period. Additionally, the stock's current price is above its 5-day, 50-day, 100-day, and 200-day moving averages, indicating a short-term upward momentum.<BR><BR>However, it is important to note that despite this recent increase, the stock has been underperforming over longer periods. For instance, it has experienced a significant decline of 43.25% over the past year, which is considerably worse than the market average return of 1.51% during the same timeframe. The company's fundamentals also show weaknesses, including a high Debt to EBITDA ratio of 4.24 times and a negative growth in operating profits over the last five years, which may contribute to cautious sentiment among investors.<BR><BR>Moreover, there has been a decrease in investor participation, with delivery volume falling by 4.58% against the 5-day average, suggesting a potential lack of confidence in the stock's long-term prospects. Institutional investors have also reduced their stake by 0.67% in the previous quarter, indicating a decline in support from more knowledgeable market participants.<BR><BR>In summary, while the stock is currently rising due to short-term gains and favorable moving averages, its long-term performance and fundamental weaknesses suggest that caution may be warranted.

View full answer

Who are in the management team of S H Kelkar & Co.?

01-Sep-2026

The management team of S H Kelkar & Co. includes Ramesh Vinayak Vaze (Chairman), Kedar Ramesh Vaze (Whole-time Director), and several non-executive and independent directors such as Shrikant Oka and Mark Elliott, along with Rohit Saraogi as Company Secretary.

The management team of S H Kelkar & Co. includes the following individuals:<BR><BR>1. **Ramesh Vinayak Vaze** - Chairman (Non-Executive)<BR>2. **Prabha Ramesh Vaze** - Non-Executive & Non-Independent Director<BR>3. **Kedar Ramesh Vaze** - Whole-time Director<BR>4. **Shrikant Oka** - Non-Executive & Independent Director<BR>5. **Mark Elliott** - Non-Executive & Independent Director<BR>6. **Vasant Gujarathi** - Independent Director<BR>7. **Neela Bhattacherjee** - Independent Director<BR>8. **Rohit Saraogi** - Company Secretary & Compliance Officer<BR>9. **Deepak Raj Bindra** - Non-Executive & Independent Director<BR><BR>If you need more information about any specific member or their roles, feel free to ask!

View full answer

What does S H Kelkar & Co. do?

01-Sep-2026

S H Kelkar & Company Ltd manufactures and exports fragrances and aroma ingredients in the specialty chemicals industry. As of June 2026, it reported net sales of ₹662 Cr and a net profit of ₹45 Cr, with a market cap of ₹2,077 Cr.

Overview:<BR>S H Kelkar & Company Ltd is engaged in the manufacture, supply, and export of fragrances and aroma ingredients, operating within the specialty chemicals industry and classified as a small-cap company.<BR><BR>History:<BR>The company was incorporated on July 1, 1955, in Mumbai, taking over businesses previously operated by Mr. V.G. Vaze and the partnership firm 'M/s Saraswati Chemical Works'. The latest quarterly results reported net sales and profit for June 2026.<BR><BR>Financial Snapshot:<BR>Net Sales: 662 Cr (Quarterly Results - Jun 2026) <BR>Net Profit: 45 Cr (Quarterly Results - Jun 2026) <BR>Market Cap: INR 2,077 Cr (Small Cap)<BR><BR>Key Metrics:<BR>P/E: 45.00 <BR>Industry P/E: 43 <BR>Dividend Yield: 0.66% <BR>Debt-Equity: 0.71 <BR>Return on Equity: 3.33% <BR>Price to Book: 1.55 <BR><BR>Contact Details:<BR>Address: Devkaran Mansion, 36 Mangaldas Road Mumbai Maharashtra : 400002 <BR>Tel: 91-22-21649163 <BR>Email: investors@keva.co.in <BR>Website: http://www.keva.co.in

View full answer

Who are the peers of the S H Kelkar & Co.?

01-Sep-2026

Peers of S H Kelkar & Co. include Jubilant Agri, Bhansali Engg., DDev Plastiks, NOCIL, Rossari Biotech, Camlin Fine, Paushak, Vidhi Specialty, Indokem, and Titan Biotech. S H Kelkar & Co. has average management risk and growth, with a 1-year return of -39.60%.

Peers: The peers of S H Kelkar & Co. are Jubilant Agri, Bhansali Engg., DDev Plastiks, NOCIL, Rossari Biotech, Camlin Fine, Paushak, Vidhi Specialty, Indokem, and Titan Biotech.<BR><BR>Quality Snapshot: Excellent management risk is observed at Jubilant Agri, DDev Plastiks, NOCIL, and Rossari Biotech, while Average management risk is found at Bhansali Engg., S H Kelkar & Co., Paushak, Vidhi Specialty, and Titan Biotech. Below Average management risk is noted at Camlin Fine and Indokem. For growth, Excellent growth is seen at Jubilant Agri, Good growth at DDev Plastiks, Average growth at Rossari Biotech, and Below Average growth at Bhansali Engg., S H Kelkar & Co., NOCIL, Camlin Fine, Paushak, Vidhi Specialty, and Titan Biotech. Capital Structure ratings show Excellent at Jubilant Agri, Bhansali Engg., DDev Plastiks, NOCIL, Rossari Biotech, and Paushak, Average at S H Kelkar & Co., and Below Average at Camlin Fine, Indokem, and Titan Biotech.<BR><BR>Return Snapshot: The peer with the highest 1-year return is Indokem at 55.94%, while the lowest is Camlin Fine at -49.11%. S H Kelkar & Co.'s 1-year return is -39.60%, which is higher than Camlin Fine's but lower than Indokem's. Additionally, the six-month return is negative for Camlin Fine, Rossari Biotech, and S H Kelkar & Co.

View full answer

How big is S H Kelkar & Co.?

01-Sep-2026

As of 31st August, S H Kelkar & Company Ltd has a market capitalization of 2,077.00 Cr, with recent Net Sales of 2,449.69 Cr and a Net Profit of 89.09 Cr.

As of 31st August, S H Kelkar & Company Ltd has a market capitalization of 2,077.00 Cr, categorizing it as a Small Cap company.<BR><BR>In the latest four quarters, the company reported Net Sales of 2,449.69 Cr and a Net Profit of 89.09 Cr.<BR><BR>The latest annual period for the balance sheet is March 2026, with Shareholder's Funds amounting to 1,361.89 Cr and Total Assets of 2,883.95 Cr.

View full answer

Are S H Kelkar & Company Ltd latest results good or bad?

29-Jul-2026

S H Kelkar & Company Ltd's latest results show strong revenue and profit growth, with a net profit increase of 77.55% year-on-year. However, concerns about margin sustainability, operational efficiency, and low return on equity suggest caution for long-term investors.

S H Kelkar & Company Ltd's latest results present a mixed picture. On one hand, the company reported a significant net profit of ₹45.40 crores for Q1 FY27, which marks a remarkable increase of 77.55% year-on-year. Revenue also grew by 14.11% to ₹662.42 crores, indicating sustained demand for its products in the fragrance and aroma sectors.<BR><BR>However, despite these headline figures, there are underlying challenges that raise concerns about the company's long-term prospects. The operating margin improved to 13.44%, but this remains volatile and below historical performance levels. The profit after tax margin of 6.80% shows that while there is growth, converting revenue into profit remains a struggle, especially when compared to previous years.<BR><BR>Additionally, the company's return on equity (ROE) has dropped to a concerning 3.32%, significantly below industry standards, indicating inefficiencies in capital utilization. The increase in employee costs outpacing revenue growth suggests potential operational inefficiencies that need to be addressed.<BR><BR>Overall, while the latest results show some positive trends, the persistent challenges in margin sustainability, operational efficiency, and capital returns suggest that the company's long-term investment appeal is questionable. Investors may want to approach with caution given these factors.

View full answer

Should I buy, sell or hold S H Kelkar & Company Ltd?

29-Jul-2026

When is the next results date for S H Kelkar & Company Ltd?

14-Jul-2026

The next results date for S H Kelkar & Company Ltd is 28 July 2026.

The next results date for S H Kelkar & Company Ltd is scheduled for 28 July 2026.

View full answer

Is S H Kelkar & Co. technically bullish or bearish?

27-Nov-2025

As of November 26, 2025, S H Kelkar & Co. is in a bearish trend with moderate strength, indicated by bearish signals from the weekly MACD, Bollinger Bands, and daily moving averages, while monthly indicators show mild bearishness.

As of 26 November 2025, the technical trend has changed from mildly bearish to bearish. The current technical stance is bearish with a moderate strength. Key indicators driving this stance include the weekly MACD and Bollinger Bands both signaling bearish conditions, along with daily moving averages also indicating a bearish trend. The monthly MACD and KST are mildly bearish, suggesting some weakness but not a strong sell signal. The Dow Theory shows no trend on a weekly basis but is mildly bearish on a monthly basis. Overall, the combination of these indicators points to a bearish outlook for S H Kelkar & Co.

View full answer

How has been the historical performance of S H Kelkar & Co.?

26-Nov-2025

S H Kelkar & Co. has shown consistent growth in net sales, reaching 2,123.40 crore in March 2025, but profitability metrics have declined, with profit after tax dropping to 75.46 crore from 123.80 crore the previous year. Total assets and liabilities increased, indicating a rise in debt to 744.85 crore, while cash flow from operating activities decreased.

Answer:<BR>The historical performance of S H Kelkar & Co. shows a consistent growth trend in net sales and total operating income over the past several years, culminating in net sales of 2,123.40 crore in March 2025, up from 1,840.83 crore in March 2024 and 1,686.52 crore in March 2023. The total operating income followed a similar trajectory, reaching 2,123.40 crore in March 2025. However, the total expenditure also increased, amounting to 1,826.39 crore in March 2025, compared to 1,537.58 crore in March 2024. Operating profit, excluding other income, was 297.01 crore in March 2025, slightly down from 303.25 crore in the previous year, while the overall operating profit stood at 320.86 crore. Profit before tax decreased to 116.19 crore in March 2025 from 183.28 crore in March 2024, leading to a profit after tax of 75.46 crore, down from 123.80 crore. The earnings per share also declined to 5.29 in March 2025 from 8.84 in March 2024. <BR><BR>In terms of assets and liabilities, total assets increased to 2,659.80 crore in March 2025 from 2,380.68 crore in March 2024, with total liabilities also rising to 2,659.80 crore. The company’s total debt rose to 744.85 crore in March 2025, compared to 616.92 crore in March 2024. Cash flow from operating activities showed a decrease to 107.00 crore in March 2024 from 196.00 crore in March 2023, while net cash inflow was positive at 32.00 crore in March 2024, following a negative outflow in the previous year. Overall, while S H Kelkar & Co. has demonstrated growth in sales and operating income, profitability metrics have shown volatility, and the increase in liabilities and debt warrants attention.<BR><BR>Breakdown:<BR>S H Kelkar & Co. has shown a steady increase in net sales, reaching 2,123.40 crore in March 2025, up from 1,840.83 crore in March 2024. This growth in total operating income mirrors the sales trend, with a total of 2,123.40 crore reported in March 2025. However, total expenditure also rose to 1,826.39 crore, impacting profitability. Operating profit, excluding other income, was slightly lower at 297.01 crore in March 2025 compared to 303.25 crore in March 2024, while the overall operating profit was 320.86 crore. Profit before tax saw a significant drop to 116.19 crore, resulting in a profit after tax of 75.46 crore, down from 123.80 crore the previous year. The earnings per share decreased to 5.29 from 8.84. On the balance sheet, total assets increased to 2,659.80 crore, with total liabilities also rising to the same figure, indicating a growing debt level of 744.85 crore. Cash flow from operating activities decreased to 107.00 crore, reflecting a challenging cash flow environment despite a positive net cash inflow of 32.00 crore in March 2024.

View full answer

Is S H Kelkar & Co. overvalued or undervalued?

11-Nov-2025

As of November 10, 2025, S H Kelkar & Co. is considered very attractive and undervalued in the specialty chemicals industry, with a PE ratio of 27.97 and a Price to Book Value of 0.20, especially compared to its expensive peers like Solar Industries and Gujarat Fluorochemicals, despite a year-to-date stock decline of 23.35%.

As of 10 November 2025, the valuation grade for S H Kelkar & Co. has moved from attractive to very attractive, indicating a significant improvement in its perceived value. The company is currently considered undervalued, particularly in comparison to its peers in the specialty chemicals industry. Key ratios include a PE ratio of 27.97, an EV to EBITDA of 30.82, and a Price to Book Value of 0.20, which suggest that the company is trading at a lower valuation relative to its earnings and assets.<BR><BR>In contrast, peers such as Solar Industries and Gujarat Fluorochemicals are classified as very expensive, with PE ratios of 96.11 and 62.86, respectively. This highlights S H Kelkar & Co.'s relative attractiveness in the market. Despite recent stock performance trailing the Sensex, with a year-to-date decline of 23.35% compared to the Sensex's gain of 6.91%, the company's strong valuation metrics suggest it may present a compelling investment opportunity moving forward.

View full answer

Who are the top shareholders of the S H Kelkar & Co.?

17-Jul-2025

The top shareholders of S H Kelkar & Co. include the Ramesh Vinayak Vaze Family Trust with 19.51%, institutional investors holding 10.98% (including 7.22% from FIIs), and individual investors at 18.6%, reflecting a strong promoter presence alongside diverse institutional and public participation.

The top shareholders of S H Kelkar & Co. include a mix of promoters, institutional investors, and individual shareholders. The majority of the shares are held by promoters, with the Ramesh Vinayak Vaze Family Trust being the largest individual shareholder, holding 19.51%. <BR><BR>In terms of institutional holdings, mutual funds collectively hold 2.76% through four schemes, while foreign institutional investors (FIIs) have a stake of 7.22% across 57 entities. The highest public shareholder is Firmenich Aromatics Production (India) Pvt Ltd, which holds 10.2%. Additionally, individual investors account for 18.6% of the shareholding. <BR><BR>Overall, the ownership structure reflects a strong presence of promoter holdings alongside significant participation from institutional and individual investors.

View full answer

Has S H Kelkar & Co. declared dividend?

06-Jun-2025

S H Kelkar & Company Ltd has declared a 7% dividend, amounting to 0.7 per share, with an ex-date of April 12, 2024. Despite the dividend declaration, the dividend yield is 0%, but the company has shown significant total returns over various periods, particularly in the long term.

S H Kelkar & Company Ltd has declared a 7% dividend.<BR><BR>Dividend Details:<BR>- Percentage announced: 7%<BR>- Amount per share: 0.7<BR>- Ex-date: 12 Apr 2024<BR><BR>Dividend Yield: 0%<BR><BR>Total Returns by Period:<BR>In the past 6 months, the price return was -12.24%, with a dividend return of 0%, resulting in a total return of -12.24%.<BR><BR>Over the last year, the price return was 27.73%, the dividend return was 0%, leading to a total return of 27.73%.<BR><BR>In the 2-year period, the price return was 104.52%, with a dividend return of 2.32%, culminating in a total return of 106.84%.<BR><BR>For the 3-year period, the price return was 89.96%, the dividend return was 2.51%, which resulted in a total return of 92.47%.<BR><BR>In the 4-year period, the price return stood at 54.59%, with a dividend return of 2.33%, leading to a total return of 56.92%.<BR><BR>Finally, over the past 5 years, the price return was 245.75%, the dividend return was 7.50%, resulting in a total return of 253.25%.<BR><BR>Overall, while S H Kelkar & Company Ltd has declared a dividend, the dividend yield remains at 0%. The total returns over various periods show significant growth, particularly over the longer term, indicating a positive trend in the company's performance despite recent fluctuations.

View full answer
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

1

Weak Long Term Fundamental Strength with a -6.22% CAGR growth in Operating Profits over the last 5 years

  • Low ability to service debt as the company has a high Debt to EBITDA ratio of 4.24 times
  • The company has been able to generate a Return on Equity (avg) of 9.04% signifying low profitability per unit of shareholders funds
2

Flat results in Jun 26

3

Falling Participation by Institutional Investors

4

Underperformed the market in the last 1 year

stock-summaryMojo Parameters

Mojo Parameters

Loading Valuation Snapshot...

Stock DNA

stock-summary
Industry

Specialty Chemicals

stock-summary
Market cap

INR 1,945 Cr (Small Cap)

stock-summary
P/E

40.00

stock-summary
Industry P/E

41

stock-summary
Dividend Yield

0.70%

stock-summary
Debt Equity

0.71

stock-summary
Return on Equity

3.33%

stock-summary
Price to Book

1.45

Revenue and Profits:
Net Sales:
662 Cr
(Quarterly Results - Jun 2026)
Net Profit:
45 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0.7%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-1.08%
0%
-1.08%
6 Months
6.0%
0%
6.0%
1 Year
-45.63%
0.42%
-45.21%
2 Years
-48.05%
0.67%
-47.38%
3 Years
-11.88%
1.80%
-10.08%
4 Years
-8.4%
3.22%
-5.18%
5 Years
-18.47%
3.51%
-14.96%

Latest dividend: 1 per share ex-dividend date: Feb-13-2026

Risk Adjusted Returns v/s stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryNews & Corporate Actions

News

S H Kelkar & Company Ltd Falls 6.73%: Mixed Technical Signals Amid Market Pressure

Announcements stock-summary

Announcement under Regulation 30 (LODR)-Press Release / Media Release

15-Sep-2026 | Source : BSE

Intimation of Sad Demise of Mr. Ramesh Vaze (DIN: 00509751) Chairman of the Company

Announcement under Regulation 30 (LODR)-Demise

15-Sep-2026 | Source : BSE

Intimation of Sad Demise of Mr. Ramesh Vaze (DIN: 00509751) Chairman of the Company

Announcement under Regulation 30 (LODR)-Change in Management

15-Sep-2026 | Source : BSE

Intimation of Sad Demise of Mr. Ramesh Vaze (DIN: 00509751) Chairman of the Company

Corporate Actions stock-summary

stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

S H Kelkar & Company Ltd has declared 10% dividend, ex-date: 13 Feb 26

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available

stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
10.53%
EBIT Growth (5y)
-6.22%
EBIT to Interest (avg)
5.07
Debt to EBITDA (avg)
2.89
Net Debt to Equity (avg)
0.71
Sales to Capital Employed (avg)
0.99
Tax Ratio
38.52%
Dividend Payout Ratio
18.90%
Pledged Shares
8.30%
Institutional Holding
11.93%
ROCE (avg)
9.64%
ROE (avg)
9.04%

Valuation key factors

Factor
Value
P/E Ratio
40
Industry P/E
41
Price to Book Value
1.38
EV to EBIT
21.90
EV to EBITDA
11.03
EV to Capital Employed
1.22
EV to Sales
1.16
PEG Ratio
NA
Dividend Yield
0.74%
ROCE (Latest)
5.29%
ROE (Latest)
3.33%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Mildly Bullish (Daily)
KST
Bullish
Bearish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
Mildly Bearish
Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Jun 2026stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

8.2954

Mutual Funds

Held by 4 Schemes (5.67%)

FIIs

Held by 49 FIIs (5.92%)

Promoter with highest holding

Ramesh Vinayak Vaze Family Trust (ramesh Vaze, Prabha Vaze & Kedar Vaze-in The Capacity Of Trustee) (19.51%)

Highest Public shareholder

Firmenich Aromatics Production (india) Pvt Ltd (9.8%)

Individual Investors Holdings

19.19%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'26 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Jun 2026 is 1.98% vs 11.27% in Mar 2026",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Jun 2026 is 2,354.05% vs -94.34% in Mar 2026",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Jun'26",
        "Mar'26",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "662.42",
          "val2": "649.58",
          "chgp": "1.98%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "88.66",
          "val2": "60.69",
          "chgp": "46.09%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "15.00",
          "val2": "14.94",
          "chgp": "0.40%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "30.53",
          "val2": "-0.74",
          "chgp": "4,225.68%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "45.40",
          "val2": "1.85",
          "chgp": "2,354.05%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "13.44%",
          "val2": "9.38%",
          "chgp": "4.06%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Consolidated) - Sep'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2025 is 12.02% vs 12.42% in Sep 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": " Growth in half year ended Sep 2025 is 174.25% vs -182.77% in Sep 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,134.52",
          "val2": "1,012.81",
          "chgp": "12.02%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "125.68",
          "val2": "159.04",
          "chgp": "-20.98%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "26.98",
          "val2": "22.71",
          "chgp": "18.80%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "2.85",
          "val2": "-120.94",
          "chgp": "102.36%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "34.75",
          "val2": "-46.80",
          "chgp": "174.25%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "11.12%",
          "val2": "15.79%",
          "chgp": "-4.67%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2025 is 10.43% vs 13.36% in Dec 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2025 is 330.23% vs -132.99% in Dec 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,718.32",
          "val2": "1,556.02",
          "chgp": "10.43%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "181.77",
          "val2": "223.58",
          "chgp": "-18.70%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "40.48",
          "val2": "36.53",
          "chgp": "10.81%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "35.92",
          "val2": "-120.94",
          "chgp": "129.70%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "67.41",
          "val2": "-29.28",
          "chgp": "330.23%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "10.58%",
          "val2": "14.37%",
          "chgp": "-3.79%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'26",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2026 is 11.48% vs 15.35% in Mar 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2026 is -5.43% vs -40.17% in Mar 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "2,367.12",
          "val2": "2,123.40",
          "chgp": "11.48%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "241.74",
          "val2": "297.01",
          "chgp": "-18.61%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "55.42",
          "val2": "49.42",
          "chgp": "12.14%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "35.90",
          "val2": "-61.62",
          "chgp": "158.26%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "69.26",
          "val2": "73.24",
          "chgp": "-5.43%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "10.25%",
          "val2": "14.06%",
          "chgp": "-3.81%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Jun'26 - QoQstock-summary

Jun'26
Mar'26
Change(%)
Net Sales
662.42
649.58
1.98%
Operating Profit (PBDIT) excl Other Income
88.66
60.69
46.09%
Interest
15.00
14.94
0.40%
Exceptional Items
30.53
-0.74
4,225.68%
Consolidate Net Profit
45.40
1.85
2,354.05%
Operating Profit Margin (Excl OI)
13.44%
9.38%
4.06%
Values in Rs Cr.
Direction Arrows
Net Sales

QoQ Growth in quarter ended Jun 2026 is 1.98% vs 11.27% in Mar 2026

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Jun 2026 is 2,354.05% vs -94.34% in Mar 2026

Half Yearly Results Snapshot (Consolidated) - Sep'25stock-summary

Sep'25
Sep'24
Change(%)
Net Sales
1,134.52
1,012.81
12.02%
Operating Profit (PBDIT) excl Other Income
125.68
159.04
-20.98%
Interest
26.98
22.71
18.80%
Exceptional Items
2.85
-120.94
102.36%
Consolidate Net Profit
34.75
-46.80
174.25%
Operating Profit Margin (Excl OI)
11.12%
15.79%
-4.67%
Values in Rs Cr.
Direction Arrows
Net Sales

Growth in half year ended Sep 2025 is 12.02% vs 12.42% in Sep 2024

Direction Arrows
Consolidated Net Profit

Growth in half year ended Sep 2025 is 174.25% vs -182.77% in Sep 2024

Nine Monthly Results Snapshot (Consolidated) - Dec'25stock-summary

Dec'25
Dec'24
Change(%)
Net Sales
1,718.32
1,556.02
10.43%
Operating Profit (PBDIT) excl Other Income
181.77
223.58
-18.70%
Interest
40.48
36.53
10.81%
Exceptional Items
35.92
-120.94
129.70%
Consolidate Net Profit
67.41
-29.28
330.23%
Operating Profit Margin (Excl OI)
10.58%
14.37%
-3.79%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2025 is 10.43% vs 13.36% in Dec 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in nine months ended Dec 2025 is 330.23% vs -132.99% in Dec 2024

Annual Results Snapshot (Consolidated) - Mar'26stock-summary

Mar'26
Mar'25
Change(%)
Net Sales
2,367.12
2,123.40
11.48%
Operating Profit (PBDIT) excl Other Income
241.74
297.01
-18.61%
Interest
55.42
49.42
12.14%
Exceptional Items
35.90
-61.62
158.26%
Consolidate Net Profit
69.26
73.24
-5.43%
Operating Profit Margin (Excl OI)
10.25%
14.06%
-3.81%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2026 is 11.48% vs 15.35% in Mar 2025

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Mar 2026 is -5.43% vs -40.17% in Mar 2025

stock-summaryCompany CV
About S H Kelkar & Company Ltd stock-summary
stock-summary
S H Kelkar & Company Ltd
Small Cap
Specialty Chemicals
S H Kelkar & Company Limited was incorporated on July 1, 1955 in Mumbai. After incorporation, the Company took over businesses carried on by Mr. V.G. Vaze as a sole proprietor of M/s S.H. Kelkar & Co and in partnership by the Firm 'M/s Saraswati Chemical Works'. The Company is engaged into manufacture, supply and exports of fragrances and aroma ingredients used in the food, beverage, personal care or household product industries.
Company Coordinates stock-summary
Company Details
Devkaran Mansion, 36 Mangaldas Road Mumbai Maharashtra : 400002
stock-summary
Tel: 91-22-21649163
stock-summary
investors@keva.co.in
Registrar Details
Link Intime India Pvt Ltd, C-13 Pannalal Silk Compound, L B S Marg, Bhandup , Mumbai